We speculate that not only VEGF concentration but also VEGFR-2 sensitivity regulates the onset of SCLS, since patients with multiple myeloma often have extremely elevated levels of serum VEGF concentration [13] without any symptoms of SCLS. This evidence concerns the gene VEGFA and plasma cell myeloma.